Dr. Mahesh S. Mulumudi

Gordon Kritzer is an Interventional Cardiologist and a Cardiologist in Issaquah, Washington. Dr. Kritzer is rated as a Distinguished provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Angina, Coronary Heart Disease, Atherosclerosis, Angioplasty, and Aortic Valve Replacement. Dr. Kritzer is currently accepting new patients.

Wayne Hwang, MD, FACC, is a board-certified cardiologist who specializes in consultative cardiology, coronary artery disease, peripheral vascular disease, peripheral arterial interventions, interventional cardiology, congestive heart failure, hypertension and functional cardiac stress testing.Dr. Hwang believes it is important to understand the disease process and to put that into the context of what the patient is going through by understanding each patient's story. He practices individualized, evidence-based medicine.Dr. Hwang serves as deputy section chief for Cardiology, and director for both the Cardiac Catheterization Laboratory and Cardiac Wellness Clinic. He also serves as a Graduate Medical Education teaching director, Cardiology division. He was named a Top Doctor by both Seattle (2013, 2014) and Seattle Metropolitan (2014) magazines. Dr. Hwang is rated as a Distinguished provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Heart Attack, Unstable Angina, Apoplexy, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

"Mariko Harper, MD, FACC is a board-certified cardiologist who specializes in all aspects of adult cardiology including: coronary artery disease, hyperlipidemia, valvular heart disease, arrhythmias, genetic/infiltrative cardiomyopathy, hypertrophic cardiomyopathy (HCM) and heart failure. She has a special expertise in advanced heart failure and advanced cardiac imaging with additional training and board certifications in both echocardiography and nuclear cardiology.Dr. Harper serves as the Medical Director of The Hypertrophic Cardiomyopathy Center at Virginia Mason Franciscan Health. Under her direction, she has created a regional center providing an individualized approach to the diagnosis, genetic testing, advanced cardiac imaging and medical/surgical management of patients with HCM. Each patient is reviewed by a multidisciplinary team of physicians and treatment plans are designed with patient input, using a shared decision making model. The HCM Center offers comprehensive HCM treatments including: medical therapy, defibrillator implantation, alcohol septal ablation and surgical septal myectomy. The HCM Center is also one of the first centers in the PNW to offer the recently FDA-approved novel HCM medication mavacamten through a comprehensive drug safety program. She also serves as a principal investigator for ongoing HCM clinical trials.Dr. Harper has authored and published multiple peer reviewed articles and book chapters in a wide range of topics in cardiology. She has been an invited speaker at both national and regional meetings on topics including hypertrophic cardiomyopathy, hyperlipidemia, and preventive cardiology. Following her passion for patient education and cardiovascular disease prevention, she is also one of the course directors for the ""Food Is Medicine"" continuing medical education lecture series at Virginia Mason Franciscan Health. Dr. Harper believes in patient-centered and patient-driven care. She emphasizes the importance of shared clinical decision making, with open dialogue between the patient and the entirety of the patient's multidisciplinary care team.Dr. Harper has been recognized as aSeattle MetTop Doctor in 2021 and 2022.In her free time, she enjoys reading, gardening, running and spending time with her family.". Dr. Harper is rated as a Distinguished provider by MediFind in the treatment of Metabolic Syndrome. Her top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Heart Failure with Preserved Ejection Fraction (HFpEF), Familial Hypertrophic Cardiomyopathy, and Cardiomyopathy.